Atlas Trials

Refractory Thyroid Gland Carcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Thyroid Gland Carcinoma

RecordFirmDate
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer (NCT05410821)The First Affiliated Hospital of Xiamen University2022-06-15
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer (NCT04061980)Providence Health & Services2020-10-30
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04284774)National Cancer Institute (NCI)2020-10-13
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (NCT03914300)National Cancer Institute (NCI)2020-02-10
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer (NCT02152995)National Cancer Institute (NCI)2014-08-14
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641)National Cancer Institute (NCI)2006-08-29

Track Refractory Thyroid Gland Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.